|Bid||38.05 x 1200|
|Ask||39.72 x 1400|
|Day's Range||38.70 - 40.48|
|52 Week Range||20.10 - 300.00|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||94.86|
Shoppers Drug Mart is partnering with TruTrace Technologies Inc. to bolster its medical cannabis retail platform.
Tilray Inc. (NASDAQ:TLRY) and Aphria Inc (TSX:APHA)(NYSE:APHA) are two marijuana stocks that you shouldn't buy unless you have a higher risk appetite.
After a solid few years, marijuana stocks like Aphria Inc (TSX:APHA)(NYSE:APHA) could collapse in the second half of 2019.
Tilray, Inc. (TLRY), a global pioneer in cannabis production, research, cultivation and distribution, today announced the expansion of its global senior leadership team with the appointment of Kristina Adamski as Executive Vice President, Corporate Affairs. In her new role, Kristina will lead Tilray’s corporate affairs team, developing the team globally and overseeing the company’s public relations, corporate social responsibility and government affairs functions.
Massive growth is coming for the global cannabis market, according to Tilray's top execs. And they think Tilray is poised to be a big winner.
CALGARY, June 13, 2019 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or the "Company") (CSE:ISH.CN - News), a Canadian company establishing a national network of adult-use cannabis stores under its Spiritleaf brand, is pleased to announce that it completed the second tranche of its previously announced cross-investment with Tilray, Inc. ("Tilray") (NASDAQ:TLRY - News) and its wholly owned subsidiary High Park Holdings Ltd. ("High Park"). Pursuant to the terms of the investment agreement entered into in December 2018, as amended, Tilray Inc. and Inner Spirit have exchanged shares valued at $1.5 million. "High Park has been a great strategic partner and partnerships like this enable our Company to grow the Spiritleaf retail brand and create value for investors in Canada's adult-use cannabis market.
The Canadian stocks trade at more than 10 times the companies’ 2020 sales, on average, while stocks of the U.S. firms go for about three times, Compass Point points out.
Tilray's Target Price: Consensus Trends Lower in JuneTilrayOn June 10, Tilray (TLRY) rose 12.1%. The company issued a press release related to a lockout period extension for one of its biggest shareholders. The shareholder accounts for nearly 77%
Valens GroWorks (CSE: VGW) (OTC: VGWCF) has expanded the volume of extraction services and has added an option to provide contract manufacturing services to the arm's length binding multi-year agreement with Tilray (NASDAQ: TLRY). Massachusetts' only cannabis company Garden Remedies (GRI) has opened its newest dispensary in Marlborough. The location commenced adult use retail operations and is awaiting […]The post Cannabis Stock News Daily Roundup June 11 appeared first on Market Exclusive.
Valens GroWorks (CSE: VGW) (OTC: VGWCF) has updated its multi-year agreement with Tilray (NASDAQ: TLRY), which is focused on cannabis research, cultivation, production, and distribution. The company has expanded the volume of extraction services and has added an option to provide contract manufacturing services to the arm's length, binding agreement announced in February with Tilray. […]The post Valens Expands Extraction Services Agreement with Tilray appeared first on Market Exclusive.
KELOWNA, BC, June 10, 2019 /CNW/ - Valens GroWorks Corp. (CSE: VGW, OTC: VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has expanded the volume of extraction services and has added an option to provide contract manufacturing services to the arm's length, binding multi-year agreement (the "Agreement") previously announced February 26, 2019 with Tilray Inc. ("Tilray") (NASDAQ:TLRY - News), a global leader in cannabis research, cultivation, production and distribution. Under the initial two-year term of the expanded Agreement, Valens will extract on a fee for service basis a minimum annual quantity of 60,000kg of dried cannabis and hemp biomass, up 300% from the 15,000kg annual commitment outlined in the original agreement.
At first glance, cannabis and cryptocurrencies seem to have a lot in common. Both comprise highly speculative markets subject to exuberant highs and crushing lows. The legality and regulation of each has languished in the gray. And to many mainstream investors, both have failed to shake synonymy with the black market.
Canadian marijuana grower Tilray and its early investors reached a deal that should prevent a flood of shares from hitting the market.
Why Has Tilray Surged Today?Tilray surgesTilray (TLRY) stock has surged today, rising 11.3% as of 11:00 AM Eastern Time. The surge came after the company announced it has signed a letter of intent with one of its shareholders, Privateer, to
Privateer Holdings Inc. has signed a non-binding letter of intent that will see it merge with Tilray. For the first year after the merger closes, the 75 million shares currently held by Privateer will only be released to institutional investors or large companies looking to make a strategic investment in the industry, and then only at the discretion of Tilray.
U.S. stocks appear ready for a rally on Monday after President Trump reached an agreement with Mexico on Friday, erasing some of last week’s trade concerns.
Privateer holds 75 million Tilray shares worth roughly $2.91 billion at Friday's closing price of $38.80. That stake was worth more than $16.05 billion at the company's peak price of $214.06 in September.
Tilray, Inc. (TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that it has signed a non-binding Letter of Intent (“LOI”) with its largest stockholder Privateer Holdings, Inc. (“Privateer”) for a transaction that will extend the lock-up on and provide for the orderly release of the 75 million Tilray shares held by Privateer to Privateer’s equity holders. Under the terms of the LOI, the parties will effect a downstream merger of Privateer with and into a wholly-owned subsidiary of Tilray, with the Tilray subsidiary surviving the merger, and the issuance by Tilray to Privateer stockholders of newly issued and registered shares of Tilray common stock in an aggregate amount equal to the number of Tilray common shares currently held by Privateer.
Jefferies analyst Owen Bennett likes Aphria and the Green Organic Dutchman, but is less impressed by Cronos Group. Where the marijuana market is going, and how to play it.